How to develop a winning pricing strategy in the post-COVID-19 consumer market
Providers and health plans should prepare for federally imposed price transparency mandates imposed by developing comprehensive pricing strategies tailored to their specific market positions, financials and operational objectives.
Price transparency as a guiding principle: directionally correct
HFMA President and CEO Joe Fifer offers a perspective on HFMA’s approach to price transparency vis-à-vis the upcoming CMS regulations on payment rate transparency.
Healthcare consumers want information personalized to their situation from health plans
HFMA's Chad Mulvany says patients and consumers need information that’s relevant to their specific clinical situation and out-of-pocket costs for price and quality information to be meaningful.
Congress may not provide a surprise bill fix prior to the election, but patients may find HFMA’s consumer guide useful
Given Congress is unlikely to provide a surprise bill fix prior to the election, Chad Mulvany suggests hospitals provide patients with HFMA's consumer guide on avoiding surprise bills to learn what questions to ask prior to any scheduled services.
State public option efforts waiver in face of the COVID-19 pandemic
HFMA's Chad Mulvany says although COVID-19 may have "dampened enthusiasm" for Washington state's public option, he is not sure the blame for its slow start rests solely, or even partly, on COVID-19.
Is another health plan featuring virtual PCPs as primary access point a sign of things to come?
HFMA's Chad Mulvany questions if the recent expansion of telehealth could stimulate a trend of plans offering virtual PCPs as the primary care access point.
CMS seeks healthcare provider comments on possible new methodology to calculate MS-DRG weights
HFMA's Chad Mulvany reviews possible technical and legal challenges CMS may face as it proposes to collect provider pricing data.
Strong financial leadership is likely key to the success of accountable communities for health
HFMA's Katie Gilfillan says strong financial leadership is required to manage and source the complex funding and ensure the long-term financial sustainability of accountable communities for health.
Questions remain on HRSA’s FAQs on billing uninsured COVID-19 claims
HFMA's Chad Mulvany says it's unclear whether IME and DSH payments are included in the "Medicare rates" that HRSA will pay hospitals for treating COVID-19 uninsured patients.
Not like the others: House Ways and Means surprise bill legislation
Provider friendly House Ways and Means surprise bill draft legislation doesn't rely on a benchmark payment rate like competing versions.